Synthesis, biological evaluation, and in vivo imaging of the first camptothecin-fluorescein conjugate

Bioconjugate Chemistry

Volumn 24, Issue 7, 2013, Pages 1119-1133

  Chevalier, Arnaud ^a   Dubois, Martine ^b,c   Le Joncour, Vadim ^b,c   Dautrey, Sébastien ^a   Lecointre, Céline ^b,c   Romieu, Anthony ^a   Renard, Pierre Yves ^a   Castel, Hélène ^b,c   Sabot, Cyrille ^a  

^a NORMANDIE UNIVERSITÉ   (France)

^b UNIVERSITÉ DE ROUEN   (France)

^c North West Cancéropole CNO   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BODY FLUIDS; CELL CULTURE; CELLS; CHEMICAL MODIFICATION; FLUORESCENCE; MOLECULAR BIOLOGY;

ANCHORINGS; ANTITUMORAL AGENTS; BIOLOGICAL EVALUATION; CAMPTOTHECIN DERIVATIVES; CAMPTOTHECINS; IN-VIVO; IN-VIVO IMAGING; PHOTOPHYSICAL PROPERTIES; RING SYSTEMS; TOPOISOMERASE I;

TUMORS;

CAMPTOTHECIN; DNA TOPOISOMERASE; FLUORESCEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CANCER INHIBITION; CELL CYCLE; CONJUGATION; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG SCREENING; DRUG SYNTHESIS; DRUG TARGETING; ENDOCYTOSIS; EX VIVO STUDY; GLIOMA CELL; IN VIVO STUDY; MOUSE; NONHUMAN; TUMOR XENOGRAFT;

EID: 84880361090     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc3005304     Document Type: Article

References (34)

1. Wall, M. E., Wani, C. M., Cook, K. H., McPhail, A. T., and Sim, G. A. (1966) Plant antitumor agents. I. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptotheca acuminate J. Am. Chem. Soc. 88, 3888-3890
2. Pommier, Y. (2009) DNA topoisomerase I inhibitors: chemistry, biology, and interfacial inhibition Chem. Rev. 109, 2894-2902
3. Negoro, S., Fukuoka, M., Masuda, N., Takada, M., Kusunoki, Y., Matsui, K., Takifuji, N., Kudoh, S., Niitani, H., and Tagushi, T. (1991) Phase I study of weekly intravenous infusions of CPT-11, a new derivative of camptothecin, in the treatment of advanced non-small-cell lung cancer J. Natl. Cancer Inst. 83, 1164-1168
4. Kawato, Y., Aonuma, M., Hirota, Y., Kuga, H., and Sato, K. (1991) Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11 Cancer Res. 51, 4187-4191
5. Kingsburry, W. D., Boehm, J. C., Jakas, D. R., Holden, K. G., Hetch, S. M., Gallagher, G., Caranfa, M. J., McCabe, F. L., Faucette, L. F., Johnson, R. K., and Hertzberg, R. P. (1991) Synthesis of water-soluble (aminoalkyl) camptothecin analogs: inhibition of topoisomerase I and antitumor activity J. Med. Chem. 34, 98-107
6. Gonçalves, M. S. T. (2009) Fluorescent labeling of biomolecules with organic probes Chem. Rev. 109, 190-212
7. Middleton, R. J. and Kellam, B. (2005) Fluorophore-tagged GPCR ligands Curr. Opin. Chem. Biol. 9, 517-525
8. Alonso, D., Vazquez-Villa, H., Gamo, A. M., Martínez-Esper, M. F., Tortosa, M., Viso, A., Fernandez de la Pradilla, R., Junquera, E., Aicart, E., Martín-Fontecha, M., Benhamú, B., Lopez-Rodríguez, M. L., and Ortega-Gutierrez, S. (2010) Development of fluorescent ligands for the human 5-HT1A receptor ACS Med. Chem. Lett. 1, 249-253
9. Redy, O. and Shabat, D. (2012) Modular theranosticprodrug based on a FRET-activated self-immolative linker J. Controlled Release 164, 276-282
10. Liu, Y.-Q., Dai, W., Tian, J. L., Yank, G., Feng, X.-W., Zhou, L., Kou, Y.-L., Zhao, W.-Q., Li, L.-H., and Li, H.-Y. (2011) Synthesis and insecticidal activities of novel spin-labeled derivatives of camptothecin Heteroat. Chem. 22, 687-691
11. Gao, M., Miller, K. D., Sledge, G. W., and Zheng, Q.-H. (2005) Radiosynthesis of carbon-11-labeled camptothecin derivatives as potential positron emission tomography tracers for imaging of topoisomerase I in cancers Bioorg. Med. Chem. Lett. 15, 3865-3869
12. Hinz, H. R., Harris, N. J., Giovanella, B. C., Ezell, E. L., and Liehr, J. G. (1996) Stabilities of 3H- and 2H-labelled camptothecins J. Label. Compd. Radiopharm. 733-742
13. Verma, R. P. and Hansch, C. (2009) Camptothecins: A SAR/QSAR Study Chem. Rev. 109, 213-235
14. Devert, M., Sabot, C., Giboreau, P., Constant, J.-F., Greene, A. E., and Kanazawa, A. (2010) Total synthesis of (±)-17-norcamptothecin, a novel E-ring modified camptothecin Tetrahedron 66, 7227-7231
15. Ziomkowska, B., Kruszewski, S., Siuda, R., and Cyrankiewicz, M. (2006) Deactivation rate of camptothecin determined by factor analysis of steady-state fluorescence and absorption spectra Optica Apllicata 1, 137-146
16. Chourpa, I., Millot, J.-M., Sockalingum, G. D., Riou, J.-F., and Manfait, M. (1998) Kinetics of lactone hydrolysis in antitumor drugs of camptothecin series as studied by fluorescence spectroscopy Biochim. Biophys. Acta 1379, 353-366
17. Kim, M., Ock, K., Cho, K., Joo, S.-W., and Lee, S. Y. (2012) Live-cell monitoring of the glutathione-triggered release of the anticancer drug topotecan on gold nanoparticles in serum-containing media Chem. Commun. 48, 4205-4207
18. Weissleder, W. and Ntziachristos, V. (2003) Shedding light onto live molecular targets Nat. Med. 9, 123-128
19. Fulmer, G. R., Miller, A. J. M., Sherden, N. H., Gottlieb, H. E., Nudelman, A., Stoltz, B. M., Bercaw, J. E., and Goldberg, K. I. (2010) NMR chemical shifts of trace impurities: common laboratory solvents, organics, and gases in deuterated solvents relevant to the organometallic chemist Organometallics 29, 2176
20. Olmsted, J. (1979) Calorimetric determinations of absolute fluorescence quantum yields J. Phys. Chem. 83, 2581-2584
21. Fang, F. G., Xie, S., and Lowery, M. W. (1994) Catalytic enantioselective synthesis of 20(S)-camptothecin: a practical application of the sharpless asymmetric dihydroxylation reaction J. Org. Chem. 59, 6142-6143
22. Massif, C., Dautrey, S., Haefele, A., Ziessel, R., Renard, P.-Y., and Romieu, A. (2012) New insights into the water-solubilisation of fluorophores by post-synthetic "click" and Sonogashira reactions Org. Biomol. Chem. 10, 4330-4336
23. Duan, Y., Liu, M., Sun, W., Wang, M., Liu, S., and Li, Q. X. (2009) Recent progress on synthesis of fluorescein probes Mini-Rev. Org. Chem. 6, 35-43
24. Kobayashi, H., Ogawa, M., Alford, R., Choyke, P. L., and Urano, Y. (2010) New strategies for fluorescent probe design in medical diagnostic imaging Chem. Rev. 110, 2620-2640
25. Comins, D. L. and Nolan, J. M. (2001) A practical six-step synthesis of (S)-camptothecin Org. Lett. 3, 4255-4257
26. Gao, J., Wang, P., and Giese, R. W. (2012) Xanthamide fluorescent dyes Anal. Chem. 74, 6397
27. Nadler, A., Hain, C., and Diederichsen, U. (2009) Histidine analog amino acids providing metal-binding sites derived from bioinorganic model systems Eur. J. Org. Chem. 4593-4599
28. Reddy, P. G., Pratap, T. V., Kumar, G. D. K., Mohanty, S. K., and Baskaran, S. (2002) The Lindlar catalyst revitalized: a highly chemoselective method for the direct conversion of azides to N-(tert-butoxycarbonyl)amines Eur. J. Org. Chem. 3740-3743
29. D'Arpa, P. and Liu, L. F. (1989) Topoisomerase-targeting antitumor drugs Biochim. Biophys. Acta 989, 163-77
30. Friedman, H. S., Keir, S. T., and Houghton, P. J. (2003) The emerging role of irinotecan (CPT-11) in the treatment of malignant glioma in brain tumors Cancer 2359-62
31. Kim, C. Y., Lee, S. J., Kim, S. K., Park, C. K., Wang, K. C., and Cho, B. K. (2012) Antitumor activity of CKD-602, a camptothecin derivative, in a mouse glioma model J. Clin. Neuro. Sci. 19, 301-305
32. Tanizawa, A., Kohn, K. W., Kohlhagen, G., Leteurtre, F., and Pommier, Y. (1995) Differential stabilization of eukaryotic DNA topoisomerase I cleavable complexes by camptothecin derivatives Biochemistry 34, 7200-7206
33. Minchinton, A. I. and Tannock, I. F. (2006) Drug penetration in solid tumours Nat. Rev. Cancer 6, 583-592
34. Grantab, R. H. and Tannock, I. F. (2012) Penetration of anticancer drugs through tumour tissue as a function of cellular packing density and interstitial fluid pressure and its modification by bortezomib BMC Cancer 12, 214